StreetAlpha.app
Home › Stocks › AMGN

Amgen Inc (AMGN)

Healthcare
$457.93
▼ −0.95%
LAST CLOSE · NOV 17

Amgen is a biopharmaceutical company based in Thousand Oaks, California, that develops and sells biological medicines. It last closed at $457.93 on Nov 17, down 0.95% on the day. AMGN reports earnings on Tue, Feb 2, 2027. The average 12-month price target from 22 analysts is $461.41 (+0.8% from the last close), with a high of $536.00 and a low of $398.00. Analyst consensus is Hold, based on the latest ratings from 22 firms (8 buy, 14 hold, 0 sell). Over the past 90 days StreetAlpha recorded 17 whale options trades in AMGN, 53% of them bullish and 47% bearish. In the past 30 days there were 25 dark pool prints totaling $29.1M, the largest $6.3M.

AI Auto Pilots
Is AMGN in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$38.9B
+8.2% vs a year ago
Net income
$9.4B
+34.1% vs a year ago
EPS (diluted)
$17.25
+33.4% vs a year ago
Free cash flow
$9.6B
24.6% margin
Valuation
Market cap
$248B
540.9M shares
P/E
26.5
Price over 12 month EPS
Price to sales
6.4
Market cap over revenue
Dividend yield
2.14%
$9.80 a share over 12 months
Balance sheet
Cash & equivalents
$13.2B
At Sep 30
Debt
$54.0B
At Sep 30
Shareholder equity
$14.4B
Shares outstanding
540.9M
At Oct 29
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $26.0B$26.0BFY2021FY2022: $26.3B$26.3BFY2022FY2023: $28.2B$28.2BFY2023FY2024: $33.4B$33.4BFY2024FY2025: $36.8B$36.8BFY2025

From AMGN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Feb 2
2027 · Time not announced
Consensus EPS forecast
$5.63
$10.45B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Hold
Based on 22 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Hold
22firms
8 Buy14 Hold0 Sell
Each firm's latest rating on AMGN in the past 90 days
Average 12-month target
$461.41
▲ 0.8% upside

Based on 22 analysts who set a price target on AMGN in the past 90 days. The average target is $461.41, with a high of $536.00 and a low of $398.00, compared with the last close of $457.93.

$313$393$473$553PAST 63 TRADING DAYS12-MONTH TARGETSHIGH $536AVG $461.41LOW $398May 26LAST CLOSE+12 MO$313$393$473$553PAST 63 DAYSTARGETSHIGH $536AVG $461.41LOW $398May 26LAST CLOSE+12 MO
Highest target$536.00
Average target$461.41
Lowest target$398.00
Latest rating changes
BarclaysTarget raised
Nov 16Hold$400 → $430
Argus ResearchTarget raised
Nov 12Buy$460 → $515
Freedom BrokerDowngrade
Nov 6Hold$470
Leerink PartnersMaintained
Nov 5Hold$464
GuggenheimTarget raised
Nov 5Hold$378 → $435
DateFirmActionRatingPrice target
Nov 16BarclaysTarget raisedHold$400 → $430
Nov 12Argus ResearchTarget raisedBuy$460 → $515
Nov 6Freedom BrokerDowngradeHold$470
Nov 5Leerink PartnersMaintainedHold$464
Nov 5GuggenheimTarget raisedHold$378 → $435
Loading…

Technical Analysis

AMGN · as of the Nov 17 close · updated after every close
Uptrend

The stock sits between its 20 and 50 day averages. It is 17% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 55). The nearest support is the Pivot S1 at $452.81, and the nearest resistance the Pivot at $458.15.

Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityHigh, 2.5%/day
Key levels
$483.9952 week high+5.7%
$483.99Swing high (Nov 5)+5.7%
$463.27Pivot R1+1.2%
$458.6720 day average+0.2%
$458.15Pivot+0.0%
$457.93Last close
$452.81Pivot S1−1.1%
$447.04Swing low (Nov 6)−2.4%
$427.1050 day average−6.7%
$412.43100 day average−9.9%
$382.18200 day average−16.5%
$312.3952 week low−31.8%
Indicators
RSI (14)55.31Middle of its rangeNeutral
MACD9.78Below its signal lineBearish
Stochastic46.6Middle of its rangeNeutral
ADX (14)36.0Trending up
Williams %R-70.5Oversold below −80, overbought above −20Neutral
CCI (20)-3.4Oversold below −100, overbought above 100Neutral
Rate of change−0.7%Change over 10 sessionsBearish
ATR (14)$11.48Typical daily range, 2.5% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for AMGN

What happened before

See how AMGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow is mixed9 bullish and 8 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow AMGN usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How AMGN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
17
Bullish
9
53%
Bearish
8
47%
Date span
Aug 21 – Nov 16
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
25
Notional
$29.1M
Largest print
$6.3M
Loading…

FLEX Options Activity

FLEX Flow →
Notable FLEX trades
None flagged
No unusually large, long-dated positions
Single-leg prints · 30D
5
$38K premium · + 10 multi-leg
Latest report
Nov 13

FLEX options are customized, exchange-listed contracts used mostly by institutions. StreetAlpha scans the daily FLEX report for unusually large, long-dated positions. Multi-leg structures, such as paired calls and puts used for financing or hedging, are listed but not counted in these totals.

Loading…

AMGN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ●1,420 buying vs 1,329 selling
  • ▼Held by funds -2.2 pts
  • ▲Funds holding +94
  • ▲Superinvestors: 2 added, 1 cut
  • ▲Put/call 1.82 to 1.72
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding3,2563,162+3.0%
In funds' top 108155+47.3%
Held by funds81.3%83.5%−2.2 pts
New / increased237 / 1,183140 / 1,239+3.0%
Reduced / sold out1,223 / 1061,197 / 125+0.5%
Put/call ratio1.721.82−5.6%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See AMGN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AMGN Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
—
 
Left in program
$6.8B
2.7% of value
Shares outstanding, 12 months
+0.5%
More shares
Last quarter
$0
Sep 2026
Avg price paid, last quarter
—
 
S&P 500 rank by spending
—
 
Spent each quarter, last 3 yearsTop bar $400.0M
Dec 2023: $0Mar 2024: $0Jun 2024: $0Sep 2024: $0Dec 2024: $400.0M, average price $278.26Mar 2025: $0Jun 2025: $0Sep 2025: $0Dec 2025: $0Mar 2026: $0Jun 2026: $0Sep 2026: $0
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 4, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AMGN is in one of them and how their past AMGN trades turned out.

AMGN in the AI portfolios
Loading…

AMGN News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered AMGN in an article yet. Here's the latest on the wider market.

AMGN Congress Trades

All congress trades →
Trades, 12 months
40
Buys
18
45%
Sells
22
55%
People
8
Last filed Nov 13
Who traded AMGN · since 2014
Latest 5 filings of 189
$1K – $15KTraded Nov 3, 2026Filed Nov 13, 2026
$1K – $15KTraded Nov 3, 2026Filed Nov 13, 2026
$1K – $15KTraded Oct 7, 2026Filed Nov 5, 2026
$15K – $50KTraded Oct 15, 2026Filed Nov 2, 2026
$1K – $15KTraded Sep 4, 2026Filed Oct 7, 2026
PersonTypeAmountTradedFiledDelay
David TaylorR · OHSell$1K – $15KNov 3, 2026Nov 13, 202610 d
David TaylorR · OHSell$1K – $15KNov 3, 2026Nov 13, 202610 d
Ro KhannaD · CASell$1K – $15KOct 7, 2026Nov 5, 202629 d
Sheldon WhitehouseD · RISell$15K – $50KOct 15, 2026Nov 2, 202618 d
Ro KhannaD · CABuy$1K – $15KSep 4, 2026Oct 7, 202633 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Amgen

Amgen is a biopharmaceutical company based in Thousand Oaks, California. It develops and sells biological products, which are medicines made from biological sources rather than diagnostic substances. Its medicines are used by patients and the healthcare providers who treat them. The company is a multinational business with operations in several countries.

Headquarters
Thousand Oaks, CA
Founded
1980